Tuesday, September 8, 2020, 7:00 AM - Wednesday, September 8, 2021, 7:00 AM PST

This episode will provide up to date insights in the association between diabetes and COVID-19. Dr. Nicolas Cuttriss will address questions about COVID and diabetes, including; Is there an increased risk of getting COVID infection if a patient has diabetes? Is there an increased risk for mortality? Are patients more at risk for getting COVID simply because they have diabetes? Who is most at risk? The elderly? Pediatric patients? How do you manage COVID in patients with diabetes? How has the pandemic changed the discussion in terms of the social determinants of health? Is telemedicine effect in managing diabetes in patients who cannot come to the clinic? Listen in to find out the answers to these questions and more. 

AMA PRA Category 1 Credits™ (0.25 hours), Non-Physician Participation Credit (0.25 hours)

1. Discuss strategies with patients to reduce their risk for COVID-19, maintain their well being and mange their care, if they do become infected.
2. Provide individualized care to your patients with diabetes, taking into account social determinants of health.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation
The Stanford University School of Medicine designates this Enduring Material for a maximum of 0.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 Credits^TM (rn.ca.gov).  Nurses will receive a Certificate of Participation following this activity that may be used for license renewal. The provider number is: 0000751.

 

References:

1.  Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters Jamie Hartmann-Boyce, Elizabeth Morris, Clare Goyder, Jade Kinton, James Perring, David Nunan, Kamal Mahtani, John B. Buse, Stefano Del Prato, Linong Ji, Ronan Roussel, Kamlesh Khunti Diabetes Care Aug 2020, 43 (8) 1695-1703; DOI: 10.2337/dc20-1192
2. Peric, S., & Stulnig, T. M. (2020). Diabetes and COVID-19 : Disease-Management-People. Wiener klinische Wochenschrift, 132(13-14), 356–361. https://doi.org/10.1007/s00508-020-01672-3
3. Tadic, M., Cuspidi, C., & Sala, C. (2020). COVID-19 and diabetes: Is there enough evidence?. Journal of clinical hypertension (Greenwich, Conn.), 22(6), 943–948. https://doi.org/10.1111/jch.13912

 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Email: stanfordmedcast@stanford.edu

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: stanfordcme@stanford.edu

The registration form for this activity is currently unavailable.

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity. 

This CME Activity is supported in part by educational grants from Novartis.